Evaluation of plasma levels of NFL, GFAP, UCHL1 and tau as Parkinson's disease biomarkers using multiplexed single molecule counting
Abstract Objective biomarkers for Parkinson’s Disease (PD) could aid early and specific diagnosis, effective monitoring of disease progression, and improved design and interpretation of clinical trials. Although alpha-synuclein remains a biomarker candidate of interest, the multifactorial and hetero...
Main Authors: | Priscilla Youssef, Laura Hughes, Woojin S. Kim, Glenda M. Halliday, Simon J. G. Lewis, Antony Cooper, Nicolas Dzamko |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Portfolio
2023-03-01
|
Series: | Scientific Reports |
Online Access: | https://doi.org/10.1038/s41598-023-32480-0 |
Similar Items
-
Plasma UCHL1, GFAP, Tau, and NfL Are Not Different in Young Healthy Persons With Mild COVID-19 Symptoms Early in the Pandemic: A Pilot Study
by: Matthew J. Rogatzki, et al.
Published: (2023-05-01) -
Serum assessment of traumatic axonal injury: the correlation of GFAP, t-Tau, UCHL-1 and NfL levels with Diffusion Tensor Imaging metrics and its prognosis utility.
by: A.M. Castaño-Leon, et al.
Published: (2022-01-01) -
Serum NFL and tau, but not serum UCHL-1 and GFAP or CSF SNAP-25, NPTX2, or sTREM2, correlate with delirium in a 3-year retrospective analysis
by: Johannes Heinrich Alexander Piel, et al.
Published: (2024-03-01) -
Plasma GFAP, NfL and pTau 181 detect preclinical stages of dementia
by: Assunta Ingannato, et al.
Published: (2024-04-01) -
Sex Differences in Behavioral Symptoms and the Levels of Circulating GFAP, Tau, and NfL in Patients With Traumatic Brain Injury
by: Dilorom Sass, et al.
Published: (2021-11-01)